Gold-von Simson Gabrielle, Rutkowski Monika, Berlin Dena, Axelrod Felicia B
Dept. of Pediatrics, New York University School of Medicine, New York, NY, USA.
Clin Auton Res. 2005 Feb;15(1):15-20. doi: 10.1007/s10286-005-0218-2.
Familial dysautonomia (FD) is a genetic disease associated with a high incidence of sudden death. If fatal bradyarrhythmia is an etiological factor then the incidence of sudden death should decrease after pacemaker placement. Retrospective review of 596 registered FD patients revealed that 22 FD patients (3.7%) had pacemakers placed between December 1984 and June 2003. Clinical and electrocardiographic indications for placement and demographic data were assessed for 20 of the 22 patients (10 males, 10 females, ages 4 to 48 years). Two patients were excluded because of insufficient data. Prior to pacemaker placement, presenting symptoms were syncope and cardiac arrest, 16/20 (80%) and 6/20 (30 %), respectively. Asystole was the most frequent electrocardiographic finding and was documented in 17/20 patients (85 %). Other electrocardiographic abnormalities included bradycardia, AV block, prolonged QTc and prolonged JTc. The average duration of pacemaker utilization was 5.7 years (range 5 months to 14.5 years). Complications included infection (1 patient) and wire migration (2 patients). In the one patient with infection, the pacemaker was permanently removed. This patient then experienced multiple syncopal episodes and death. There were 7 other deaths. Three deaths occurred suddenly without preceding events, and 4 patients had non-cardiac causes of death. None of these 7 deceased patients had recurrence of syncope after pacemaker placement. In the 12 surviving patients, 6 had recurrence of syncope but none had cardiac arrest. Pacemaker placement may protect FD patients from fatal bradyarrhythmia and may decrease the incidence of syncope. However, data are limited and prospective analysis is needed.
家族性自主神经功能异常(FD)是一种与猝死高发生率相关的遗传性疾病。如果致命性缓慢性心律失常是一个病因,那么在植入起搏器后猝死发生率应该会降低。对596例注册的FD患者进行回顾性研究发现,在1984年12月至2003年6月期间有22例FD患者(3.7%)植入了起搏器。对这22例患者中的20例(10例男性,10例女性,年龄4至48岁)进行了植入的临床和心电图指征以及人口统计学数据评估。2例患者因数据不足被排除。在植入起搏器之前,主要症状分别为晕厥和心脏骤停,各占20例中的16例(80%)和6例(30%)。心脏停搏是最常见的心电图表现,20例患者中有17例(85%)记录到该表现。其他心电图异常包括心动过缓、房室传导阻滞、QTc延长和JTc延长。起搏器使用的平均时长为5.7年(范围为5个月至14.5年)。并发症包括感染(1例患者)和导线移位(2例患者)。在1例感染患者中,起搏器被永久取出。该患者随后经历了多次晕厥发作并死亡。还有7例其他死亡病例。3例患者无先兆事件突然死亡,4例患者有非心脏原因导致的死亡。这7例死亡患者在植入起搏器后均未出现晕厥复发。在12例存活患者中,6例有晕厥复发,但均未发生心脏骤停。植入起搏器可能会保护FD患者免受致命性缓慢性心律失常的影响,并可能降低晕厥的发生率。然而,数据有限,需要进行前瞻性分析。